Dataset from A Phase 3 Clinical Study to Determine the Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor : Recombinant Factor VIII (rVWF:rFVIII) and rVWF in the Treatment of Bleeding Episodes in Subjects Diagnosed With Von Willebrand Disease
收藏NIAID Data Ecosystem2026-05-10 收录
下载链接：
https://doi.org/10.25934/00006624
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this Phase 3 study is to assess the pharmacokinetics of rVWF:rFVIII and rVWF,
and to assess the safety and efficacy of rVWF:rFVIII and rVWF in the treatment of bleeding
events in subjects with severe hereditary von Willebrand disease (VWD).
创建时间：
2025-10-29
